Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R3421 in moderate to severe chronic plaque psoriasis
NCT00504270Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Ulodesine in plaque psoriasis (3 arms), sponsored by Roche. Primary endpoints: Adverse events (AEs), Laboratory parameters and 1 more. Started Jul 2007; status: completed.
02
Drugs
Ulodesine
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00504270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00504270.